Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 12.85 M15.08 M — Research & development 1.41 M1.52 M — Operating income 5.86 M7.64 M — Non-Operating Income, Total 13.33 M1.09 M — Interest expense, net of interest capitalized 216 K78 K — Non-Operating Income, excl. Interest Expenses 11.72 M-197 K — Unusual income/expense 1.4 M1.21 M — Pretax income 19.2 M8.73 M — Equity in earnings —— — Taxes 00 — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 19.2 M8.73 M — Discontinued operations —— — Net income 19.2 M8.73 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 19.2 M8.73 M — Basic earnings per share (Basic EPS) -165.53-0.64 — Diluted earnings per share (Diluted EPS) -165.53-0.64 — Average basic shares outstanding 115.97 K13.6 M — Diluted shares outstanding 115.97 K13.6 M — EBITDA -5.22 M-6.87 M — EBIT -5.86 M-7.64 M — Cost of revenue 2.62 M2.79 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 643 K768 K —